Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 56

Related Articles by Review for PubMed (Select 10860393)

1.

Hypervitaminosis A and bone.

Binkley N, Krueger D.

Nutr Rev. 2000 May;58(5):138-44. Review.

PMID:
10860393
2.

Vitamin A supplementation and risk of skeletal fracture.

Genaro Pde S, Martini LA.

Nutr Rev. 2004 Feb;62(2):65-7. Review.

PMID:
15080368
3.

Is vitamin A consumption a risk factor for osteoporotic fracture?

Barker ME, Blumsohn A.

Proc Nutr Soc. 2003 Nov;62(4):845-50. Review.

PMID:
15018484
4.

Hypervitaminosis A syndrome: a paradigm of retinoid side effects.

Silverman AK, Ellis CN, Voorhees JJ.

J Am Acad Dermatol. 1987 May;16(5 Pt 1):1027-39. Review.

PMID:
3294938
5.

[Strontium ranelate: a novel concept for the treatment of osteoporosis].

Dimai HP.

Wien Klin Wochenschr. 2005 Nov;117(21-22):728-38. Review. German.

PMID:
16416353
6.

Optimizing bone metabolism in osteoporosis: insight into the pharmacologic profile of strontium ranelate.

Marie PJ.

Osteoporos Int. 2003;14 Suppl 3:S9-12. Epub 2003 Mar 18. Review.

PMID:
12730801
7.

Strontium ranelate: a novel mode of action optimizing bone formation and resorption.

Marie PJ.

Osteoporos Int. 2005 Jan;16 Suppl 1:S7-10. Review.

PMID:
15578159
8.

Mechanisms of osteoporosis in spinal cord injury.

Jiang SD, Jiang LS, Dai LY.

Clin Endocrinol (Oxf). 2006 Nov;65(5):555-65. Review.

PMID:
17054455
9.

Osteoporosis after spinal cord injury.

Jiang SD, Dai LY, Jiang LS.

Osteoporos Int. 2006 Feb;17(2):180-92. Epub 2005 Oct 11. Review. Erratum in: Osteoporos Int. 2006;17(8):1278-81.

PMID:
16217589
10.

Effects of vitamin K2 on osteoporosis.

Iwamoto J, Takeda T, Sato Y.

Curr Pharm Des. 2004;10(21):2557-76. Review.

PMID:
15320745
11.
12.

Parathyroid hormone: an anabolic treatment for osteoporosis.

Morley P, Whitfield JF, Willick GE.

Curr Pharm Des. 2001 May;7(8):671-87. Review.

PMID:
11375775
13.

Regulatory mechanism of food factors in bone metabolism and prevention of osteoporosis.

Yamaguchi M.

Yakugaku Zasshi. 2006 Nov;126(11):1117-37. Review.

14.

Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.

Seeman E.

Osteoporos Int. 2003;14 Suppl 3:S2-8. Epub 2003 Mar 19. Review.

PMID:
12730770
15.

[Hormones and osteoporosis update. Calcitonin, CGRP and bone].

Ozono K.

Clin Calcium. 2009 Jul;19(7):929-34. doi: CliCa0907929934. Review. Japanese.

PMID:
19567987
16.

Vitamin D, osteoclastogenesis and bone resorption: from mechanistic insight to the development of new analogs.

Ikeda K.

Endocr J. 2007 Feb;54(1):1-6. Epub 2006 Sep 7. Review. No abstract available.

17.

Interventions to prevent bone loss in astronauts during space flight.

Iwamoto J, Takeda T, Sato Y.

Keio J Med. 2005 Jun;54(2):55-9. Review.

18.

[Mesenchymal stem cells. Potential use in cell and gene therapy of bone loss caused by aging and osteoporosis].

Justesen J, Stenderup K, Kassem MS.

Ugeskr Laeger. 2001 Oct 1;163(40):5491-5. Review. Danish.

PMID:
11601113
19.

Dietary phyto-oestrogens and bone health.

Branca F.

Proc Nutr Soc. 2003 Nov;62(4):877-87. Review.

PMID:
15018488
20.

The potential of parathyroid hormone as a therapy for osteoporosis.

Rubin MR, Bilezikian JP.

Int J Fertil Womens Med. 2002 May-Jun;47(3):103-15. Review.

PMID:
12081255
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk